⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21621447 | 0.69 | — | — | |
| SCHEMBL24001579 | 0.69 | — | — | |
| SCHEMBL9427967 | 0.62 | — | — | |
| SCHEMBL24836115 | 0.62 | — | — | |
| SCHEMBL22433363 | 0.60 | — | — | |
| SCHEMBL581024 | 0.59 | — | — | |
| SCHEMBL29324765 | 0.58 | — | — | |
| SCHEMBL24767311 | 0.58 | — | — | |
| SCHEMBL19508315 | 0.57 | GBA1 (0.50) | — | |
| SCHEMBL16883020 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718617-B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of use | AMGEN INC. (US) | 2023-08-08 | — | — | US | disclosed |